FY2022 EPS Estimates for Addus HomeCare Co. Reduced by Oppenheimer (NASDAQ:ADUS)

Addus HomeCare Co. (NASDAQ:ADUSGet Rating) – Equities researchers at Oppenheimer cut their FY2022 earnings estimates for Addus HomeCare in a research note issued to investors on Thursday, January 19th. Oppenheimer analyst M. Wiederhorn now expects that the company will post earnings of $3.11 per share for the year, down from their prior estimate of $3.13. The consensus estimate for Addus HomeCare’s current full-year earnings is $3.11 per share. Oppenheimer also issued estimates for Addus HomeCare’s Q1 2023 earnings at $0.76 EPS, Q2 2023 earnings at $0.86 EPS, Q3 2023 earnings at $0.90 EPS and Q4 2023 earnings at $0.98 EPS.

Addus HomeCare (NASDAQ:ADUSGet Rating) last released its quarterly earnings data on Monday, October 31st. The company reported $0.80 EPS for the quarter, missing the consensus estimate of $0.81 by ($0.01). Addus HomeCare had a net margin of 4.77% and a return on equity of 8.46%. The company had revenue of $240.50 million during the quarter, compared to analyst estimates of $242.21 million. During the same quarter in the prior year, the firm earned $0.80 earnings per share. Addus HomeCare’s revenue for the quarter was up 11.0% on a year-over-year basis.

Several other equities analysts also recently commented on the stock. StockNews.com downgraded shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a report on Saturday, January 14th. Royal Bank of Canada upped their price target on shares of Addus HomeCare from $110.00 to $121.00 and gave the company an “outperform” rating in a research note on Wednesday, November 2nd. Six equities research analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock has a consensus rating of “Buy” and an average price target of $112.60.

Addus HomeCare Price Performance

NASDAQ:ADUS opened at $109.83 on Monday. Addus HomeCare has a one year low of $68.57 and a one year high of $112.89. The company has a market cap of $1.77 billion, a P/E ratio of 39.94, a P/E/G ratio of 2.78 and a beta of 0.82. The firm’s fifty day moving average price is $104.67 and its two-hundred day moving average price is $99.32. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.87 and a quick ratio of 1.87.

Insider Activity at Addus HomeCare

In related news, EVP Michael D. Wattenbarger sold 377 shares of the company’s stock in a transaction dated Monday, December 12th. The shares were sold at an average price of $103.54, for a total value of $39,034.58. Following the transaction, the executive vice president now directly owns 6,387 shares in the company, valued at $661,309.98. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In related news, CEO R Dirk Allison sold 700 shares of the company’s stock in a transaction dated Thursday, November 3rd. The shares were sold at an average price of $108.00, for a total transaction of $75,600.00. Following the completion of the sale, the chief executive officer now owns 80,554 shares of the company’s stock, valued at $8,699,832. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Michael D. Wattenbarger sold 377 shares of the company’s stock in a transaction dated Monday, December 12th. The stock was sold at an average price of $103.54, for a total transaction of $39,034.58. Following the sale, the executive vice president now directly owns 6,387 shares of the company’s stock, valued at approximately $661,309.98. The disclosure for this sale can be found here. Over the last three months, insiders have sold 32,714 shares of company stock worth $3,524,933. Corporate insiders own 4.50% of the company’s stock.

Institutional Investors Weigh In On Addus HomeCare

Several institutional investors and hedge funds have recently bought and sold shares of ADUS. Altshuler Shaham Ltd bought a new stake in Addus HomeCare during the third quarter worth about $28,000. Assetmark Inc. lifted its holdings in shares of Addus HomeCare by 110.1% in the second quarter. Assetmark Inc. now owns 374 shares of the company’s stock worth $31,000 after acquiring an additional 196 shares during the last quarter. UMB Bank n.a. lifted its holdings in shares of Addus HomeCare by 321.5% in the third quarter. UMB Bank n.a. now owns 333 shares of the company’s stock worth $32,000 after acquiring an additional 254 shares during the last quarter. First Horizon Advisors Inc. lifted its holdings in shares of Addus HomeCare by 109.7% in the third quarter. First Horizon Advisors Inc. now owns 369 shares of the company’s stock worth $35,000 after acquiring an additional 193 shares during the last quarter. Finally, Point72 Hong Kong Ltd bought a new position in shares of Addus HomeCare in the second quarter worth about $41,000. Institutional investors own 97.42% of the company’s stock.

About Addus HomeCare

(Get Rating)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal Care, Hospice, and Home Health.

Recommended Stories

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.